维基百科,自由的百科全书
SGT-152![](https://upload.wikimedia.org/wikipedia/commons/thumb/2/2d/CUMYL-NBMINACA_structure.png/220px-CUMYL-NBMINACA_structure.png) |
|
[1-(bicyclo[2.2.1]heptan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
|
CAS号 | 1631074-60-6 Y |
---|
PubChem CID | |
---|
CompTox Dashboard (EPA) | |
---|
|
化学式 | C25H29N3O |
---|
摩尔质量 | 387.53 g·mol−1 |
---|
3D模型(JSmol) | |
---|
CC(C)(C1=CC=CC=C1)NC(=O)C2=NN(C3=CC=CC=C32)CC4CC5CCC4C5
|
InChI=1S/C25H29N3O/c1-25(2,20-8-4-3-5-9-20)26-24(29)23-21-10-6-7-11-22(21)28(27-23)16-19-15-17-12-13-18(19)14-17/h3-11,17-19H,12-16H2,1-2H3,(H,26,29) Key:MLRLLZWQYJJPEX-UHFFFAOYSA-N
|
SGT-152是一种有机化合物,化学式为C25H29N3O,化学名称为1-(双环[2.2.1]庚烷-2-基)甲基-N-(2-苯丙-2-基)-1H-吲唑-3-甲酰胺(英語:Cumyl-BC[2.2.1]HpMINACA,缩写CUMYL-NBMINACA)[1]。它最初在2014年公开的一份专利中作为合成大麻素被报道[2],后于2021年在德国的法医实验室被认作为狡詐家藥物[3]。
- ^ Benedikt Pulver, Jan Riedel, Torsten Schönberger, Michael Pütz, Jan Schäper, Natalie Kunert, Klaus Putzer, Gunter Hermann, Volker Auwärter, Folker Westphal. Comprehensive structural characterisation of the newly emerged synthetic cannabimimetics Cumyl-BC[2.2.1]HpMeGaClone, Cumyl-BC[2.2.1]HpMINACA, and Cumyl-BC[2.2.1]HpMICA featuring a norbornyl methyl side chain. Forensic Chemistry. 2021-12, 26: 100371 [2022-12-02]. doi:10.1016/j.forc.2021.100371 (英语).
- ^ Bowden; et al. Patent WO 2014167530 - Cannabinoid compounds. New Zealand Patent application 623626. 11 April 2013 [2 December 2022]. (原始内容存档于2016-05-09).
- ^ New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System June 2022[失效連結]